Zilebesiran
ALN-AGT01-008
Phase 3 small_molecule active
Quick answer
Zilebesiran for High Risk Cardiovascular Disease is a Phase 3 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- High Risk Cardiovascular Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active